Biotechnology, Pharmaceuticals

Biofit 2015

Ariane - 25-nov.-2015 00:04:08

Date begin : 1th december 2015 Date End : 2th december 2015 Join the 4th edition of BioFit on December 1st & 2nd 2015 in Strasbourg, France +1 day SPECIAL INVITATION to a Franco-German-Swiss Excellence Event on November 30th. BIOFIT is the leading business convention in Europe for open Innovation, technology transfer and collaborative research in Life Sciences. More than 1300 participants will attend the 2015 edition, which will be held in Strasbourg (Alsace region), at the heart of the Franco-German-Swiss BioValley Cluster, a center of excellence for therapeutic innovation I www.biofit-event.com   Public & Private collaborations BioFIT is the leading partnering event in Europe for Open Innovation, technology transfer and collaborative research in the field of Life Sciences, with the highest attending rate of academia, TTOs and research institutes together with big pharma, emerging and small biotech companies, medtech and diagnostics companies.   Engage new partnerships Foster the emergence of collaborative projects Intensify the flow of licenses in the field of life sciences Who will you meet? The event gathers leaders from pharma, biotech, medtech, IVD companies, investors, as well as professionals from technology transfer and academia. Website : http://www.biofit-event.com/ Registration for Biofit : http://www.biofit-event.com/registration/registration-fees/  


Biotechnology in France

Yannick Bezin - 04-avr.-2014 00:50:43

  Biotechnology in France Even though biotechnologies may be a recent sector of business activity, France has succeeded in developing real know-how that is gaining international recognition.   When it comes to biotechnologies, the French are cutting edge. According to Leeme, the federation of French medical companies, today France numbers 388 biotechs in the health field in France. Biotech France, another French association for biotech companies, indicates that a third of these companies have been in existence for over 10 years. Yet the number of creations in this field is exponential. To get an idea, 50 companies were started in 2012. Unheard of! Proof that there is a real entrepreneurial effervescence when it comes to this research in France. Young start-ups for the most part, French biotechs are mainly Small Medium sized companies. Only 4% of them have over 100 employees. On average, they employ 22 people. As to the type of activity, most of the French companies specialized in human sciences with therapeutic products are concentrated on cancer treatments. “The French have developed a full-fledged know-how on cardio-vascular devices, infectious diseases, dermatology, blood diseases and for surgery,” explains Yves Germani, Ubifrance’s manager for the health sector in North America.   French enterprises don’t just do research; they discover! Altogether, the French biotech industry generated 261 Million Euros in turnover in 2011, compared with 186 Million in 2010. As for companies on the stock market, they generate 369 Million Euros in turnover. Concerning the pipeline, the expression used to indicate the number of molecules being developed, France is 4rth, behind the United Kingdom, Germany, Switzerland and Israel. Quite a solid ranking, but which should nevertheless be improved. When their results are examined in detail, we see that depending on the stage of development, French companies create more products in the pre-clinic phase, in other words, all those that have been carried out before the clinical trial with patients, which is completely logical. Between the start of development on a new medicine, a molecule and its release on the market can sometimes take up to 10 years. Unfortunately, the consequence of this is that a number of products fall by the wayside. To be noted, however, is one undeniable fact: since 2008, French companies have sold more and more products. To put it another way, as Yves Germani points out, French companies don’t just do research; they discover!”   An increase of 63% in investment Even more impressive than all the rest, French biotech companies tend to have smaller R&D budgets than their European and international competitors. Fortunately, the culture of venture capital is developing very quickly in this sector. To give the general picture, the funds raised by French biotechs have increased by 63,1% from 2009 to 2012, reaching 178 Million Euros. Since the year 2000, they have managed to raise 2.920 Billion Euros. Today, French companies are naturally turning towards international opportunities to find new partners and new financial leverage. The proof is that such Small Medium companies as Affilogic, MedinCell, Interactive Biosoftware, Imabiotech or even O4CP all have one thing in common: they all are reaching out with confidence to mature markets like the United States, Canada and Western Europe.


About
The department of Fashion, Homeware, Health and Beauty facilitates business between French-based companies and Australian companies, agents, importers and distributors. It covers the sectors of Cosmetic, Medical, Pharmaceutical, Medical equipment, biotechnology, Textile, Jewelry, Luxury Products, Decoration, Renovation, DIY, Boating, Music, Sport and Leisure. Most of our international companies such as Sisley, L’Oréal, C. Dior, La Mer, La Prairie, Clarins, Biotherm, Guerlain, Louis Vuitton, Hermes, Cartier, Lacoste, Sanofi, Pierre Favre, Stallergenes, or Le Coq Sportif operate successfully in Australia.  However, French SMEs can also bring their expertise and “savoir faire” when they team up with local players able to master the local context. In 2015, the MHS team is organising two major events on both Beauty and Fashion sectors and biotechnology sector, bringing French brands in Australia to liaise with local partners and be part of B2B fair

READ MORE

Facebook
Press area & Media Gallery
List of last comments

A nice healthcare innovation

Tanaka Yamaguchi | avril 06, 2014

A nice healthcare innovation

Tanaka Yamaguchi | avril 06, 2014

Et si t'as pas de gaffe passe amarre...

Harmandeep | mars 08, 2013

I would just will like to inform all the...

Martine carole Fougere USA Distributor DESMAZIERES DRINO Las Vegas NV | février 07, 2013